Omega Healthcare Investors, Inc.

As of October 3, 2025, Omega Healthcare Investors, Inc. shows a mildly bullish trend with mixed signals from indicators, underperforming the S&P 500 in the short term but maintaining a year-to-date return of 8.72%.

As of October 3, 2025, Omega Healthcare Investors, Inc. has a mildly bullish technical trend, with positive momentum indicators, but it has underperformed the S&P 500 recently, returning -1.65% and -3.13% over the past week and month, respectively, while year-to-date it has returned 8.72% compared to the S&P 500's 14.18%.

As of September 3, 2025, Omega Healthcare Investors, Inc. has shifted to a bullish trend with strong indicators, despite underperforming the S&P 500 over the past year and several years, though it has a positive year-to-date return of 10.28%.

As of June 9, 2025, Omega Healthcare Investors, Inc. shows a mildly bearish trend, indicated by daily moving averages and weekly KST, despite a mildly bullish weekly MACD, with overall sentiment influenced by the monthly MACD and OBV being bearish.

As of March 2022, the management team of Omega Healthcare Investors, Inc. includes Independent Chairman Mr. Craig Callen, CEO and Director Mr. C. Taylor Pickett, and several Independent Directors: Mr. Kevin Jacobs, Ms. Kapila Anand, Ms. Barbara Hill, Mr. Edward Lowenthal, and Mr. Stephen Plavin. They oversee the company's operations and strategic direction.

Omega Healthcare Investors, Inc. is a self-administered REIT that invests in long-term healthcare facilities and mortgages. As of March 2025, it reported net sales of $278 million and a market cap of approximately $10.68 billion, with a dividend yield of 6.15%.

As of Jun 18, Omega Healthcare Investors, Inc. has a market capitalization of $10.68 billion, with net sales of $1.09 billion and a net profit of $460.52 million over the latest four quarters.